Schedule 13G ownership disclosure

ESSA PHARMA INC

Common Shares · CUSIP: 29668H708

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 1,904,062 · Class: 4.0%

  • Morgan Stanley & Co. LLC

    Shares: 0 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000531
Form type
SCHEDULE 13G/A
Filer
ESSA Pharma Inc.
CIK
CIK 1633932
Filed
Oct 07, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub